RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 50.00 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-04-15
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-12-31 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-06-30 was 0.00 shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-03-31 was 50.00K shares.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 50.00K shares, a 83.33% decline from fiscal 2023.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 300.00K shares, a 40.30% decline from fiscal 2022.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 502.50K shares, a 509.09% increase from fiscal 2021.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 82.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-04-15 | 0.00 shares derived: sum of 3 quarters · filed 2026-04-15 | 50.00K shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-18 | 50.00K shares 10-Q · filed 2024-11-18 | 50.00K shares derived: sum of 4 quarters · filed 2025-03-31 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | 50.00K shares 10-Q · filed 2024-08-19 | 50.00K shares derived: sum of 3 quarters · filed 2025-03-31 | |
| 2024-03-31 | 50.00K shares 10-Q · filed 2024-05-20 | 50.00K shares derived: sum of 2 quarters · filed 2025-03-31 | ||
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 300.00K shares 10-K · filed 2025-03-31 | ||
| 2023-09-30 | 300.00K shares 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 502.50K shares 10-K · filed 2024-04-01 | ||
| 2022-09-30 | 502.50K shares 10-Q · filed 2022-11-17 | |||
| 2021-12-31 | 62.50K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-15 | 82.50K shares 10-K/A · filed 2023-06-15 | ||
| 2021-09-30 | 20.00K shares 10-Q · filed 2021-11-22 |